Phase 1B/2 Study of PAC-1 and Entrectinib for Patients with Metastatic Uveal Melanoma

Status: Open to Accrual

Learn more:

• clinicaltrials.gov: #NCT04589832

Study Contact: studies@hoosiercancer.org; (317) 921-2050.